Compare Lustrum:Modalis Therapeutics Corporation:4883

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Modalis Therapeutics Corporation Go to web site 4883 Medicals 東証グロース December 1, 2000 2020.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Modalis Therapeutics Corporation Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Modalis Therapeutics Corporation Balance Sheet 2023年12月期 Modalis Therapeutics Corporation Balance Sheet 2022年12月期 Modalis Therapeutics Corporation Balance Sheet 2021年12月期 Modalis Therapeutics Corporation Balance Sheet 2020年12月期 Modalis Therapeutics Corporation Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
1,883down
(93.0%)down
2,933down
(93.7%)up
4,936down
(81.3%)down
5,421up
(86.4%)down
3,857
(97.9%)
Other Current AssetsHelp
(Percent)
73down
(3.6%)down
128down
(4.1%)up
131up
(2.2%)up
27up
(0.4%)down
18
(0.5%)
Tangible Fixed AssetsHelp
(Percent)

-

-
224up
(3.7%)up
50up
(0.8%)down
49
(1.2%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
705down
(11.6%)down
768up
(12.2%)down
705
(17.9%)
Investments and OthersHelp
(Percent)
70up
(3.4%)up
69down
(2.2%)up
73up
(1.2%)up
11up
(0.2%)up
-691
(-17.5%)
Total AssetsHelp
(Percent)
2,026
(100%)
3,130
(100%)
6,069
(100%)
6,277
(100%)
3,938
(100%)
Total Current LiabilitiesHelp
(Percent)
233up
(11.5%)up
189down
(6.0%)down
520up
(8.6%)up
70down
(1.1%)down
96
(2.4%)
Total Long-term LiabilitiesHelp
(Percent)
413
(20.4%)
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
1,380down
(68.1%)down
2,941down
(94.0%)up
5,549down
(91.4%)down
6,207up
(98.9%)up
3,843
(97.6%)
Total LiabilitiesHelp
(Percent)
2,026
(100%)
3,130
(100%)
6,069
(100%)
6,277
(100%)
3,938
(100%)

Modalis Therapeutics Corporation Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Modalis Therapeutics Corporation Profit and Loss Account 2023年12月期 Modalis Therapeutics Corporation Profit and Loss Account 2022年12月期 Modalis Therapeutics Corporation Profit and Loss Account 2021年12月期 Modalis Therapeutics Corporation Profit and Loss Account 2020年12月期 Modalis Therapeutics Corporation Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
0
(100%)
41
(100%)
1
(100%)
342
(100%)
645
(100%)
Total Sales
(Percent)
0
(100%)
41
(100%)
1
(100%)
342
(100%)
645
(100%)
Cost of SalesHelp
(Percent)

-

-

-

-

-
Other Costs and RevenueHelp 2,392down
2,743up
(6,773.4%)down
740down
(67,277.9%)up
790up
(231.1%)up
504
(78.2%)
Total CostsHelp 2,392 2,743 740 790 504
Net RevenueHelp
-

-

-

-

-
Earnings Before TaxHelp -2,391up
-2,707down
(-6,684.0%)up
-745down
(-67,765.2%)down
-440down
(-128.5%)down
146
(22.7%)
Net IncomeHelp -2,392up
-2,703down
(-6,673.4%)up
-739down
(-67,177.9%)down
-448down
(-131.1%)down
141
(21.8%)
当期純利益 -2,392 -2,703 -739 -448 141

Modalis Therapeutics Corporation Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Modalis Therapeutics Corporation Cash Flow Statement 2023年12月期 Modalis Therapeutics Corporation Cash Flow Statement 2022年12月期 Modalis Therapeutics Corporation Cash Flow Statement 2021年12月期 Modalis Therapeutics Corporation Cash Flow Statement 2020年12月期 Modalis Therapeutics Corporation Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-2,254down
(-98.3%)down
-1,896down
(-91.1%)up
-747down
(-100.0%)down
-377down
(-13.6%)down
224
(8.3%)
Investing Cash Flow(ICF)Help
(Percent)
-40up
(-1.7%)up
-186down
(-8.9%)down
172up
(23.0%)up
-830down
(-29.9%)down
-62
(-2.3%)
Financing Cash FlowHelp
(Percent)
1,216up
(53.0%)up
64down
(3.1%)down
73down
(9.7%)down
2,778up
(100.0%)up
2,491
(91.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
28up
(1.2%)up
15down
(0.7%)down
18up
(2.4%)up
-7down
(-0.2%)down
-1
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -1,050up
(-45.8%)up
-2,003down
(-96.2%)down
-485down
(-64.9%)down
1,564down
(56.3%)down
2,652
(97.7%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Modalis Therapeutics Corporation

Company where related level is highHelp

Medrx Co.,Ltd.
RIBOMIC Inc.
ASKA Pharmaceutical Co.,Ltd.
Chiome Bioscience Inc.
Immuno-Biological Laboratories Co., Ltd.
D.Western Therapeutics Institute, Inc.
SanBio Company Limited
MIZUHO MEDY CO.,LTD.
JCR Pharmaceuticals Co.,Ltd.
SSP CO.,LTD.